19th Annual Cardiome
19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. George L. Bakris
14 août 2024 12h00 HE | Cardiometabolic Health Congress
Boca Raton, FL, Aug. 14, 2024 (GLOBE NEWSWIRE) -- For nearly two decades, Dr. George L. Bakris was a pillar of the Cardiometabolic Health Congress (CMHC), generously sharing his expertise, passion,...
NodThera_logo.jpg
NodThera Named a ‘Fierce 15’ Company by Fierce Biotech
05 août 2024 10h16 HE | NodThera
NodThera Named a ‘Fierce 15’ Company by Fierce Biotech Philadelphia, PA, August 5, 2024 - NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic...
Tourmaline_logo.jpg
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
02 août 2024 16h30 HE | Tourmaline Bio, Inc.
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
NodThera_logo.jpg
NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer
01 août 2024 07h00 HE | NodThera
NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer Greg brings over 25 years of public and private company leadership experience Philadelphia, PA, August 1, 2024 -...
U.S. Cardiology Procedures Market
U.S. Cardiology Procedures Market Analysis Report 2024-2030: Interventional Procedures, Peripheral Vascular Procedures, Heart Rhythm Management Procedures Size, Share & Trends
11 juil. 2024 10h41 HE | Research and Markets
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "U.S. Cardiology Procedures Market Size, Share & Trends Analysis Report by Procedures (Interventional Procedures, Peripheral Vascular Procedures,...
111Boehringer_Ingelheim_Logo_RGB_Dark_Green (002).png
Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
07 juin 2024 04h30 HE | Boehringer Ingelheim
News builds on previously announced primary endpoint, which showed up to 83.0% of adults achieved statistically significant improvement in metabolic dysfunction-associated steatohepatitis (MASH)...
Tourmaline_logo.jpg
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
16 mai 2024 07h00 HE | Tourmaline Bio, Inc.
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
Research Nester Logo.jpg
Drug Delivery Systems Market revenue to exceed USD 433 Billion by 2035, says Research Nester
18 mars 2024 05h00 HE | Research Nester
New York, March 18, 2024 (GLOBE NEWSWIRE) -- The global drug delivery systems market size is slated to expand at ~11% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 433...
Cardiology IT Workflow Solutions Market
Global Cardiology IT Workflow Solutions Research Report 2024: Market to Reach $1.8 Billion by 2030 - Artificial Intelligence (AI) to Revolutionize Cardiology Workflow Management
01 mars 2024 06h16 HE | Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Cardiology IT Workflow Solutions - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Cardiology IT...
Global Pediatric Interventional Cardiology Market
Global Pediatric Interventional Cardiology Market Report 2024 - Stents Segment Shows Prominence and is Forecast to Dominate the PIC Market in the Coming Years
28 févr. 2024 04h02 HE | Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "Global Pediatric Interventional Cardiology Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company...